MARCO and breast cancer: Although MARCO has been previously reported as a pro-tumor TAM marker in non-small cell lung cancer [43], lung adenocarcinoma [54], and breast cancer [44], and has been associated with poor prognosis in periampullary adenocarcinoma [45], its role has not been previously reported in GBM.